drugset / Trial / NCT07395271
Comparing Doses of Intrathecal Dexmedetomidine
RandomizedParallel-groupDouble-blindHealth-services research
Summary
To compare the duration of sensory and motor blockade produced by two different intrathecal doses of dexmedetomidine (5 µg and 10 µg) when added to hyperbaric bupivacaine in patients undergoing elective cesarean section
Timeline
- Start
- 2025-10-22
- Primary completion
- 2026-01-21
- Completion
- 2026-01-21
Publications
- Results Mowar A, Singh V, Pahade A, Karki G. Effect of three different doses of intrathecal dexmedetomidine on subarachnoid block: a prospective randomized double-blind trial. Anaesth. pain intensive care 2021;26(1):8-13; DOI:10.35975/apic.v26i1.1759
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 5 ug | Intrathecal |
| Comparator | Dexmedetomidine | Other / unclassified | 10 ug | Intrathecal |
| Comparator | Bupivacaine | Other / unclassified | 12.5 mg | Intrathecal |
Indications
No indication recorded.